Published in Prostaglandins on January 01, 1987
Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol (1975) 10.52
Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods (1997) 1.89
Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem (1998) 1.72
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
Vitamin D supplementation reduces airway hyperresponsiveness and allergic airway inflammation in a murine model. Clin Exp Allergy (2013) 1.70
Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol (1975) 1.68
Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun (1998) 1.52
Genetic analysis of allergic disease in twins. J Allergy Clin Immunol (1984) 1.46
The presence of airway reactivity before the development of asthma. Am Rev Respir Dis (1990) 1.32
Biochemical study of certain enzymes and metabolites of the carbohydrate metabolism in the skeletal muscle of the dengue virus-infected mice. J Gen Virol (1978) 1.25
(+)-1-(3S,4R)-[3-(4-phenylbenzyl)-4-hydroxychroman-7-yl]cyclopentane carboxylic acid, a highly potent, selective leukotriene B4 antagonist with oral activity in the murine collagen-induced arthritis model. J Med Chem (1994) 1.19
Obstructive lung disease in hereditary alpha 1-antitrypsin deficiency. JAMA (1970) 1.19
Difference between lung and spleen susceptibility of beta-adrenergic receptors to desensitization by terbutaline. J Allergy Clin Immunol (1983) 1.14
Segregation analysis of bronchial response to methacholine inhalation challenge in families with and without asthma. J Allergy Clin Immunol (1986) 1.11
The effect of age on methacholine response. J Allergy Clin Immunol (1985) 1.09
Effect of hydrocortisone on beta-adrenergic receptors in lung membranes. Life Sci (1979) 1.08
Neuropeptides modulate human eosinophil chemotaxis. J Immunol (1992) 1.07
Retracted Effects of platelet activating factor on cyclic AMP accumulation in human lymphocytes. Ann Allergy (1992) 1.07
Notice of retraction. Effects of platelet activating factor on cyclic AMP accumulation in human lymphocytes. Ann Allergy (1992) 1.07
Interpretation of the results of methacholine inhalation challenge tests. J Allergy Clin Immunol (1987) 1.06
Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol (1998) 1.06
Glucocorticoids increase pulmonary beta-adrenergic receptors in fetal rabbit. Endocrinology (1980) 1.06
Mycobacterial antigens attenuate late phase response, airway hyperresponsiveness, and bronchoalveolar lavage eosinophilia in a mouse model of bronchial asthma. Int Immunopharmacol (2001) 1.05
Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds. J Pharmacol Exp Ther (1984) 1.04
The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696. J Pharmacol Exp Ther (1995) 1.03
Duration and specificity of sodium cromolyn on allergen inhalation challenges in asthmatics. J Allergy Clin Immunol (1974) 1.03
Comparison of respiratory and cardiovascular effects of isoproterenol, propranolol, and practolol in asthmatic and normal subjects. J Allergy Clin Immunol (1976) 1.03
Methacholine inhalation challenge studies in a selected pediatric population. Am Rev Respir Dis (1986) 1.02
Effect of terfenadine on the bronchoconstriction induced by ultrasonically nebulized distilled water. Ann Allergy (1988) 1.02
The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691). Clin Pharmacol Ther (2011) 1.01
Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol Life Sci (1998) 1.01
C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study. Allergy (2011) 1.00
Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med (1996) 1.00
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase. J Med Chem (1998) 0.98
Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease. J Cell Mol Med (2008) 0.97
A comparison of stent-induced stenosis in coronary and peripheral arteries. J Clin Pathol (2006) 0.96
Pharmacological characterization of effects of nifedipine on isolated guinea-pig and rat tracheal smooth muscle. Arch Int Pharmacodyn Ther (1983) 0.95
Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol (1996) 0.95
Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis (2005) 0.94
Bronchial reactivity to histamine before and after sodium cromoglycate in bronchial asthma. Br Med J (1976) 0.94
The effect of beta adrenergic blockade on bronchial sensitivity to acetyl-beta-methacholine in normal and allergic rhinitis subjects. J Allergy Clin Immunol (1976) 0.94
[3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site. J Pharmacol Exp Ther (1986) 0.94
Methacholine inhalation challenge studies. J Allergy Clin Immunol (1979) 0.93
Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs. J Pharmacol Toxicol Methods (1998) 0.93
Bronchial reactivity pattern in nonasthmatic parents of asthmatics. Ann Allergy (1988) 0.92
Protective effect opf lodoxamide tromethamine on allergen inhalation challenge. J Allergy Clin Immunol (1980) 0.91
Endogenous nitric oxide in allergic airway disease. J Allergy Clin Immunol (2000) 0.91
Cl- channels are expressed in human normal monocytes: a functional role in migration, adhesion and volume change. Clin Exp Immunol (2004) 0.89
Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of the beta adrenergic receptors. J Allergy (1967) 0.89
Functional and morphological evaluation of canine veins following preservation in different storage media. J Surg Res (1997) 0.88
Effect of platelet-activating factor on beta-adrenoceptors in human lung. Biochem Biophys Res Commun (1987) 0.87
Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery. J Cardiovasc Pharmacol (1987) 0.87
Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation (1993) 0.86
Glucocorticosteroids inhibit leukotriene production. Ann Allergy Asthma Immunol (1997) 0.86
Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret. J Med Chem (1996) 0.86
Ischemia-induced peripheral arterial vasospasm role of alpha 1- and alpha 2-adrenoceptors. J Surg Res (1996) 0.86
Calcium channel antagonists in coronary artery spasm and bronchial spasm. What do variant angina and bronchial asthma have in common? Chest (1982) 0.85
Insulin like growth factor-1 activates nuclear factor-kappaB and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cells. Cardiovasc Surg (1999) 0.85
A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report. Eur J Respir Dis Suppl (1986) 0.84
Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. Biochem Biophys Res Commun (1987) 0.84
Successful treatment of a giant exposed blood vessel in a gastric ulcer by endoscopic sclerotherapy with N-butyl-2-cyanoacrylate. Endoscopy (2007) 0.84
Preparation and evaluation of transdermal plasters containing norfloxacin: a novel treatment for burn wound healing. Eplasty (2010) 0.84
Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology (1996) 0.84
The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. Allergy Proc (1991) 0.84
Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. Int Immunopharmacol (2001) 0.84
Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation. J Immunol (1988) 0.84
A noninjury, diet-induced swine model of atherosclerosis for cardiovascular-interventional research. Angiology (1996) 0.83
Tissue distribution and functional correlation of [3H]leukotriene C4 and [3H]leukotriene D4 binding sites in guinea-pig uterus and lung preparations. J Pharmacol Exp Ther (1985) 0.83
[A case of ulcerative colitis after total colectomy associated with diffuse duodenitis]. Nihon Shokakibyo Gakkai Zasshi (1997) 0.83
Lymphocyte glucocorticoid receptors in asthmatic and control subjects. Clin Allergy (1984) 0.82
Distribution of methacholine inhalation challenge responses in a selected adult population. J Allergy Clin Immunol (1987) 0.82
Fetal pulmonary beta-adrenergic receptors: characterization in the human and in vitro modulation by glucocorticoids in the rabbit. Pediatr Pulmonol (1986) 0.82
Cromolyn therapy in patients with bronchial asthma. Effect on inhalation challenge with allergen, histamine, and methacholine. JAMA (1976) 0.82
Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. J Vasc Surg (1997) 0.82
Regulation of tumour necrosis factor production by adrenal hormones in vivo: insights into the antiinflammatory activity of rolipram. Br J Pharmacol (1996) 0.82
Association of MS Pi phenotype with airway hyperresponsiveness. Chest (1990) 0.81
The mechanism of corticosteroids in treating asthma. Ann Allergy (1987) 0.81
Safety of nifedipine in subjects with bronchial asthma and COPD. Chest (1984) 0.81